On August 19, 2026, a Form 4 filing revealed that David J. Wilson, President and CEO of Columbus McKinnon Corp (NASDAQ:CMCO) CMCO (NASDAQ:CMCO) ,
Dow Jones futures: S&P 500, Nasdaq rise as Moderna, Merck, gold shine but not these techs
The S&P 500 and Nasdaq rose slightly Wednesday as Treasury yields fell. Moderna and Merck fueled big gains for biotechs, drugmakers.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty suggests a strong opening; US, Asian markets gain
Wall Street indices ended higher on Wednesday with S&P 500 snapped a three-day losing run as bond yields fell. The S&P 500 added 0.21%
Stock market today: Indexes snap 3-session skids, bond yields drop as Treasury Dept. increases buyback of longer-term notes
Major U.S. stock indexes closed higher Wednesday following three consecutive days of declines, and bond yields fell, after the Treasury Department announced it would
Broadcom drags Nasdaq lower as Dow and S&P 500 climb to new highs
Broadcom’s 143% AI chip revenue surge wasn’t enough for investors, triggering a $286 billion market cap loss and dragging the Nasdaq lower as the
Huge Unusual Put Options Volume in Merck – Is MRK Stock Overvalued?
A Barchart report shows that despite recent strong Q2 results and a 10% spike in Merck stock today, an unusually large volume of put
Stock market today: Dow breaks losing streak as Moderna catapults on its cancer vaccine win (live coverage)
Stock Market Today: The Dow Jones index rises Wednesday on Treasury buybacks. Moderna soars on cancer vaccine news.
China’s backflipping robots leap to blockbuster stock market debut in latest sign of AI boom
Unitree’s shares closed up 460% on Wednesday, a significant marker as Beijing competes for global tech dominance with Washington.
Getting in on single-stock futures? Watch for these potential tax surprises
Single-stock futures are enticing for active retail traders, but they may come with unintended tax consequences.
Globus Medical Director Stephen T. Zarrilli Executes Stock Options and Sells Shares on August 18, 2026
On August 19, 2026, Director Stephen T. Zarrilli submitted a Form 4 to the SEC, detailing his exercise of stock options and same-day sale